Vermillion Announces Patent for AD Biomarkers, Second Peer-Reviewed Paper on OVA1

The patent covers the use of the proteins saposin D and Fam3c as biomarkers for Alzheimer's disease, while the paper, published this week in the online edition of Obstetrics & Gynecology, demonstrates that OVA1 has increased sensitivity and decreased specificity compared to conventional ovarian cancer tests.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.